Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Arlene L Oei"'
Autor:
Anna C. Nuijens, Arlene L. Oei, Lisa Koster, Ron A. Hoebe, Nicolaas A.P. Franken, Coen R.N. Rasch, Lukas J.A. Stalpers
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background A predictive assay for late radiation toxicity would allow more personalized treatment planning, reducing the burden of toxicity for the more sensitive minority, and improving the therapeutic index for the majority. In a previous
Externí odkaz:
https://doaj.org/article/22edc391216a45a5a7f4fc0566347cc8
Autor:
Yasmin A. Civil, Arlene L. Oei, Katya M. Duvivier, Nina Bijker, Philip Meijnen, Lorraine Donkers, Sonja Verheijen, Zdenko van Kesteren, Miguel A. Palacios, Laura J. Schijf, Ellis Barbé, Inge R. H. M. Konings, C. Willemien Menke -van der Houven van Oordt, Paulien G. Westhoff, Hanneke J. M. Meijer, Gwen M. P. Diepenhorst, Victor Thijssen, Florent Mouliere, Berend J. Slotman, Susanne van der Velde, H. J. G. Desirée van den Bongard
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Partial breast irradiation (PBI) is standard of care in low-risk breast cancer patients after breast-conserving surgery (BCS). Pre-operative PBI can result in tumor downstaging and more precise target definition possibly resulting
Externí odkaz:
https://doaj.org/article/dc6a0f20cb054375986fc9996c89d8ed
Autor:
Daan R. Löke, H. Petra Kok, Roxan F. C. P. A Helderman, Bella Bokan, Nicolaas A. P. Franken, Arlene L. Oei, Jurriaan B. Tuynman, Pieter J. Tanis, Johannes Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 40, Iss 1 (2023)
AbstractIntroduction Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) aims to treat microscopic disease left after CytoReductive Surgery (CRS). Thermal enhancement depends on the temperatures achieved. Since the location of microscopic disease is un
Externí odkaz:
https://doaj.org/article/82b13eeeab604bdaaa4d2a2d094dad54
Autor:
Roxan F. C. P. A. Helderman, Bella Bokan, Gregor G. W. van Bochove, Hans M. Rodermond, Elsy Thijssen, Wouter Marchal, Arezo Torang, Daan R. Löke, Nicolaas A. P. Franken, H. Petra Kok, Pieter J. Tanis, Johannes Crezee, Arlene L. Oei
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionIn patients with limited peritoneal metastasis (PM) originating from colorectal cancer, cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a potentially curative treatment option. This combined tr
Externí odkaz:
https://doaj.org/article/d035d5b08b89485c9c0226c89d4560a8
Publikováno v:
STAR Protocols, Vol 4, Iss 1, Pp 102098- (2023)
Summary: Severe combined immunodeficient mice are typically used for xenografting experiments and show reliable tumor engraftment; however, their Prkdscid mutation renders them highly sensitive to irradiation. Here, we describe a protocol that allows
Externí odkaz:
https://doaj.org/article/2e8eb186a3b745398376ff9a07098a84
Autor:
Daan R. Löke, H. Petra Kok, Roxan F. C. P. A. Helderman, Nicolaas A. P. Franken, Arlene L. Oei, Jurriaan B. Tuynman, Remko Zweije, Jan Sijbrands, Pieter J. Tanis, Johannes Crezee
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCytoReductive Surgery (CRS) followed by Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) is an often used strategy in treating patients diagnosed with peritoneal metastasis (PM) originating from various origins such as gastric, colorecta
Externí odkaz:
https://doaj.org/article/077ef8fcb12f4e8392aaf6f13e6b5182
Autor:
Daan R. Löke, Roxan F. C. P. A. Helderman, Hans M. Rodermond, Pieter J. Tanis, Geert J. Streekstra, Nicolaas A. P. Franken, Arlene L. Oei, Johannes Crezee, H. Petra Kok
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 38-54 (2021)
Background Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after cytoreductive surgery (CRS). During HIPEC, fluid (41–43 °C) is administered and drained through a limited number of catheters,
Externí odkaz:
https://doaj.org/article/9bad3523b2e647ac8b0e7cf89a722b30
Autor:
Daan R. Löke, Roxan F. C. P. A. Helderman, Nicolaas A. P. Franken, Arlene L. Oei, Pieter J. Tanis, Johannes Crezee, H. Petra Kok
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 145-161 (2021)
Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after debulking cytoreductive surgery. During HIPEC, a limited number of catheters are used to administer and drain fluid containing chemotherapy
Externí odkaz:
https://doaj.org/article/a2b892d19472473faa89e3eb2261f7a1
Autor:
Arlene L. Oei, Preethi Korangath, Kathleen Mulka, Mikko Helenius, Jonathan B. Coulter, Jacqueline Stewart, Esteban Velarde, Johannes Crezee, Brian Simons, Lukas J. A. Stalpers, H. Petra Kok, Kathleen Gabrielson, Nicolaas A. P. Franken, Robert Ivkov
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 0, Pp 47-63 (2019)
Purpose: Enhancing immune responses in triple negative breast cancers (TNBCs) remains a challenge. Our study aimed to determine whether magnetic iron oxide nanoparticle (MION) hyperthermia (HT) can enhance abscopal effects with radiotherapy (RT) and
Externí odkaz:
https://doaj.org/article/373ac4be0e8649e7bbb04b8ecf130b94
Autor:
Yasmin A. Civil, Lysanne W. Jonker, Maartje P. M. Groot Koerkamp, Katya M. Duvivier, Ralph de Vries, Arlene L. Oei, Berend J. Slotman, Susanne van der Velde, H. J. G. Desirée van den Bongard
Publikováno v:
Civil, Y A, Jonker, L W, Groot Koerkamp, M P M, Duvivier, K M, de Vries, R, Oei, A L, Slotman, B J, van der Velde, S & van den Bongard, H J G D 2023, ' Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer : A Systematic Review of Literature ', Annals of Surgical Oncology, vol. 30, no. 6, pp. 3263-3279 . https://doi.org/10.1245/s10434-023-13233-9
Background Preoperative instead of standard postoperative partial breast irradiation (PBI) after breast-conserving surgery (BCS) has the advantage of reducing the irradiated breast volume, toxicity, and number of radiotherapy sessions and can allow t